This chapter examines the biological effects of ionizing radiation at the organ and tissue level. It discusses how radiation can cause cell death leading to visible changes in organs and tissues. The effects are initially seen as inflammation, edema and hemorrhage, which can progress to fibrosis, atrophy and obstruction with increased dose. Skin is an early responding tissue, with effects ranging from transient erythema to ulceration and necrosis depending on the radiation dose and area exposed.
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Â
Radiation's Effects on Organs & Systems
1. Radiation Pathology
Chapter 6
(Part 1)
This chapter examines
ionizing radiationâs effects
at the biological level of
major organs and organ
systems
2. Cell death and the subsequent cell
loss from the organ/tissue is
the initial event that leads
to visible changes.
3. The visible effects of radiation (at the
level of organs and tissues) are not
unique to radiation. Other causes might
produce the same visible effects,
for example:
ī§Thermal Burns
ī§Chemical injuries
ī§Allergic reactions
ī§Disease processes
4. âAcuteâ vs. âChronicâ Effects
In this chapter, these terms are not
necessarily being used to describe when a
response occurs in terms of time units after
irradiation. They are being used to describe
different âphasesâ of response, with different
underlying causes of the response.
Additionally, either term may be describing
effects that can result from either âchronicâ or
âacuteâ radiation exposure conditions.
5. In this sense, âacuteâ effects refer to the first
(or initial) phase of response [regardless of
whether it occurs after a brief or a long time after
irradiation]; and, the cause is depletion (loss)
of parenchymal cells from the organ/tissue.
âĸExample (from textbook);
âĸEsophagitis (acutely responding basal cell loss)
âĸPneumonitis (late responding alveolar epithelial cells)
âĸNote: both are acute effects.
6. âChronicâ Effects [Also Sometimes
Called âLateâ Effects] Occur As:
1. A secondary result of progressive
early changes (âSecondary Chronic
Effectsâ)
2. A result of loss of critical non-
parenchymal cells (âPrimary Chronic
Effectsâ)
7. âSecondaryâ chronic effects are more
likely to appear sooner and progress
more quickly than âprimaryâ
chronic effects.
8. Healing of Tissue and Organs
īŽ Two basic mechanisms of healing
īŽ Regeneration
īŽ Repair
9. Regeneration: Replacement of
Damaged Cells by Same Type
of Cells.
īŽ Reverses early radiation changes
īŽ Restores organ or tissue to its pre-
irradiated state.
10. Repair: Replacement of
Depleted Original Cells
by Different Cell Types
īŽ Follows catastrophic and irreversible
acute changes
īŽ Does not restore organ to its pre-
irradiated condition.
11. Type of Healing Depends On:
īŽ Magnitude of the radiation dose
īŽ The specific organ or tissue
irradiated.
12. âRegenerationâ Mostly Occurs:
1. After low to moderate doses
2. In tissues with whose cells normally
divide (or retain ability to divide)
[regeneration may even be possible
after high doses in such
organs/tissues]
13. âRepairâ Mostly Occurs:
1. After high radiation doses
2. In late responding organs/tissues with
slowly dividing or non-dividing cells
15. Factors Influencing Response
īŽ Total dose (normally, dose is relatively
low for diagnostic clinical modalities like
nuclear medicine or radiography)
īŽ Dose rate
īŽ Fractionation
īŽ Volume irradiated
16. Volume Effects
īŽ Partial irradiation may leave enough
undamaged organ to allow continued
sufficient function (and therefore
survival of the individual organism).
19. Specific Organ System
Response
īŽ âSystemâ means a collection or
grouping of anatomically or
functionally related organs or
tissues.
20. Hemopoietic System
(Also Called âHematopoieticâ System)
īŽ Pertaining to function of blood cells
īŽ Consists of:
īŽ Bone Marrow
īŽ Circulating blood
īŽ Lymph Nodes
īŽ Spleen
īŽ Thymus
21. Bone Marrow Consists Of:
īŽ Parenchymal cells of marrow (stem
cells, material end cells in
circulating blood, and fat cells)
īŽ Stromal connective tissue
22. Two Types of Marrow in
Adults
īŽ âRedâ contains stem cells for supplying
mature functional cells. Found in ribs,
ends of long bones, vertebra, sternum,
skull bones
īŽ âYellowâ consists primarily of fat cells
and has few stem cells.
23.
24. Primary Radiation Response
of Marrow Is a Decrease in
Stem Cells.
īŽ Low Doses: Slight decrease with full
recovery in weeks.
īŽ Moderate to high doses: more severe
depletion; longer recovery times;
permanent decrease in stem cell
numbers and increase in fat and
connective tissue (higher doses).
25. All marrow stem cells are radiosensitive but,
relatively speaking, sensitivity varies.
In order or sensitivity (highest to lowest):
1. Erythroblasts (RBC precursors)
2. Myelocytes (some WBC precursors)
3. Megakaryocytes (platelet precursors)
28. Changes in numbers of circulating blood cells of
each type will be seen, due to the death of
precursor stem cells (and the sensitivity of the
mature lymphocyte).
īŽ Observed changes dependent on:
īŽ The relative radiosensitivity of the different
precursor stem cells (and of the mature
lymphocyte)
īŽ The lifespan of each circulating blood cell
type (cell turnover)
29. Dose Effects
īŽ Lymphocytes decrease at doses as low
as 10 rad (0.1 Gy).
īŽ Neutrophils at doses of about 50 rad
(0.5 Gy).
īŽ Platelets and RBCs at doses above 50
rad.
30. Timing â Circulating Blood
Cell Numbers Reach A
Minimum:
īŽ Within a few days post-exposure for
lymphocytes
īŽ Within about a week post-exposure for
granulocytes
īŽ Within about 4 weeks post-exposure for
platelets
īŽ Over about 90 to 120 days post-
exposure for RBCs
34. Nuc.Med. Administrations Produce
an Observable Change in CBC
Counts?
īŽ Examples:
īŽ Tc-99m sulfur-colloid (8mci, IV injection,
adults)
īŽ Tc-99m mertiatide (MAG3) (20mci, IV
injection, adults)
īŽ Tc-99m sodium pertechnetate (30mci, IV
injection, adults)
35.
36.
37.
38. Sulfur Colloid:
0.36 rad (marrow, normal liver)
[can be 0.63 rad in pt. with advanced liver disease]
0.15 rad total body
[Note: Total body dose approximates dose to
circulating blood cells]
Resulting Red Marrow and Total Body Doses
39. Resulting Red Marrow and
Total Body Dose (Adult)
īŽ Mertiadide:
īŽ 0.050 rem/10 mci x 20mci = 0.1 rem
(marrow)
īŽ 0.065 rem/10 mci x 20mci = 0.130 rem
(total body)
40. Resulting Red Marrow and
Whole Body Doses (resting)
īŽ Pertechnetate:
īŽ 0.57 rad/30 mCi (red marrow)
īŽ 0.42 rad/30 mCi (total body)
41. Question: Would changes in circulating blood
cell counts be observable for these diagnostic
studies?
Answer: NO!
42. What About Therapy Doses?
īŽ Typical I-131 thyroid cancer dosage:
100 to 200 mCi (oral administration)
43.
44. Red Marrow and Whole Body
Doses (Euthyroid Patients)
īŽ I-131 Na-lodide, 25% uptake (worst
case)
īŽ Red marrow:
īŽ 0.26 Rad/mCi x 100 mCi = 26 Rad
īŽ 0.26 Rad/mCi x 200 mCi = 52 Rad
īŽ Total body:
īŽ 0.71 Rad/mCi x 100 mCi = 71 Rad
īŽ 0.71 Rad/mCi x 200 mCi = 141 Rad
45. Would Changes in CBC Counts Be
Observable for the Preceding I-131
Doses?
īŽ Quite possibly, especially for circulating
mature lymphocytes; possibly for other
white blood cell types (at 200 mCi); but
not for platelets or RBCs.
46. Note
Also:
īŽ The doses indicated are delivered over
the total time it takes to eliminate I-131.
For euthyroid (normally functioning)
thyroid individuals, the effective half-life
(combined radiological and elimination
half-lives) is about 6.5 days.
īŽ This means thatâĻâĻâĻâĻâĻâĻâĻ.
47. About half of the dose is delivered over the
course of 6.5 days, 75% over 13 days, 87.5%
over 19.5 days; and it takes over 6 weeks to deliver
99% of the dose.
Result is reduced effectiveness in reducing
circulating blood counts.
Effective Half-Life (TEFF) = TR x TB
-------------
TR + TB
TR = Radiological Half-Life
T = Biological Elimination Half-Life
48. Also: Euthyroid Patients Should Not
Be Getting Therapy I-131 Doses!!!
īŽ For actual therapies, marrow and total
body doses per millicurie will be lower
because biological elimination is faster
(Teff is about 3.5 days for hyperthyroid
patients; <20 hours [usually closer to 14
hours] for post-thyroidectomy patients).
55. Epidermis Subdivided Into
Layers Made Up Of:
īŽ At the outermost surface (âstratum
corneumâ), dead cells
īŽ Mature, non-dividing cells (just under
the stratum corneum)
īŽ Immature, dividing cells at the base of
the epidermis (the âbasalâ layer)
59. 59
īŽ Total skin area is about 2 m2
.
īŽ Weight of skin is about 2.1 kg.
īŽ Role of skin
īŽ Physical barrier to protect the body from hazards in
the environment
īŽ Cools the body
īŽ Heat retention
īŽ Sensory system for the external environment
īŽ Epidermis â 25% of dermal tissue by dry weight
īŽ Dermis â 75% of dermal tissue by dry weight
Structure of SkinStructure of Skin
Ref: ICRP Pub. 59
60. 60
īŽ Stratum corneum
īŽ 15 to 20 layers of dead
cells
īŽ Thicker on palms of
hands and soles of feet.
īŽ Stratum granulosum
īŽ 4 to 5 layers of cells
īŽ Become flattened and
lose nucleus
īŽ Become the stratum
corneum
Structure of SkinStructure of Skin
www.biology-online.org
61. 61
īŽ Stratum spinosum
īŽ Variable number of cell
layers
īŽ Stratum germinativum
īŽ Single layer of cells
īŽ Referred to as the basal
layer
īŽ Stratum germinativum and
spinosum are the two
layers which determines
the response to radiation
induced injuries.
Structure of SkinStructure of Skin
www.biology-online.org
62. 62
īŽ The dermis is composed of two layers:
the superficial papillary dermis and the
reticular dermis.
Structure of SkinStructure of Skin
www.biology-online.org
63. 63
īŽ Papillary dermis
īŽ consists of thin collagen
bundles interwoven with
elastic fibers
īŽ Richly vascularized
īŽ Provides thermoregulation
and maintains metabolic
requirements of the basal
layer.
www.biology-online.org
Structure of SkinStructure of Skin
64. 64
īŽ Reticular dermis
īŽ Primary structural
and mechanical
component of skin
īŽ Densely fibrous
īŽ Fewer blood cells
and vessels than
papillary dermis
Structure of SkinStructure of Skin
www.biology-online.org
66. 66
Radiation Effects on Skin
īŽ Transient Erythema
īŽ Main Erythema
īŽ Temporary and Permanent Epilation
īŽ Dry desquamation
īŽ Moist desquamation
īŽ Ulceration
īŽ Late Erythema
īŽ Dermal Atrophy
īŽ Telangiectasia
īŽ Necrosis
67.
68. 68
Skin Effects
īŽ Target cells for:
īŽ Cancer effects â 20 to 100 Âĩm
īŽ Deterministic effects â 300 to 500 Âĩm
69. 69
Radiation Effects on Skin
īŽ More than 50% of basal cells are at a depth of 200 Âĩm,
distributed in the shaft of hair follicles.
īŽ Total radiation dose of the basal layer and time between
repeat exposures will determine the severity of the damage.
īŽ The size of the skin area exposed will determine the long-
term effects.
īŽ As the dose increases, the number of viable basal and
clonogenic cells decreases.
īŽ As the number of viable basal cells decreases beyond 50%,
the skin stem cells respond by rapidly producing more basal
cells.
Ref: ICRP Pub. 59
70.
71. âĸTransit times for cells to go from basal (stem)
cell layer to the surface is 12 to 48 days
âĸEpidermis is âearly respondingâ
âĸDermis is âlate respondingâ
76. 76
Radiation Effects on Skin
īŽ Electrophysiology and ablation procedure
with a bi-plane fluoroscopy unit
Wagner LK, Radiation injury is a potentially serious complication to
fluoroscopically-guided complex interventions, Biomed Imaging Interv J 2007;
3(2):e22
77.
78. 78
Radiation Effects on Skin
īŽ Dry desquamation
īŽ An atypical
thickening of the
stratus corneum
that may or may
not be observed.
82. 82
(a) Early erythema and developing moist desquamation in a diabetic woman
caused by a localization radiographic exposure.
Balter S et al. Radiology 2010;254:326-341
Š2010 by Radiological Society of North America
Radiation Effects on Skin
83. 83
Radiation Effects on Skin
īŽ Moist desquamation
īŽ Sloughing of the epidermis and exposure
of the dermal layer clinically characterizes
moist desquamation.
84.
85.
86.
87. 87
Radiation Effects on Skin
īŽ Ulceration and
necrosis
īŽ Basal layer and
clonogenic cells
sterilized
īŽ Surrounding skin
not able to send
new cells
īŽ Epidermis
sloughs off
Interact CardioVasc Thorac Surg 2011;12:290-292. doi:10.1510/icvts.2010.247395
Š 2011 European Association of Cardio-Thoracic Surgery
95. The dose required to produce erythema is
called (logically), a âSkin Erythema Doseâ
(SED)
âSEDâ was historically used as a âunitâ to
quantify radiation exposure to individuals.
96. Chronic Changes:
(Following higher doses or repeated
lower doses over long periods of time)
īŽ Atrophy (thinning) of epidermis
īŽ Fibrosis
īŽ Pigmentation changes
īŽ Ulceration (high doses required)
īŽ Necrosis (high doses required)
97.
98.
99. Effects on Skin: Accessory
Structures
īŽ Hair follicles
īŽ Temporary epilation at 300-600 rad
īŽ Permanent epilation above 600 rad
īŽ Sweat and sebaceous glands
īŽ Atrophy and fibrosis (late responses,
chronic effects) following high doses
100. 100
Radiation Effects on Skin
īŽ Epilation â hair loss
īŽ Cells at the base of
the hair follicle are
affected.
īŽ Detectable hair loss
after 6 weeks
occurs in about
50% of subjects at
5-10 Gy.
LA Times
Balter S et al. Radiology 2010;254:326-341
Š2010 by Radiological Society of North America
101. 101
Effect
Time to
Onset
Dose
Threshold
(Gy)
Transient
Erythema
2-24 hrs 2
Main Erythema 10 d 6
Temporary
Epilation
3 wks 3
Permanent
Epilation
3 wks 7
Dry desquamation 4 wks 14
Moist
desquamation
4 wks 18
Ulceration >6wks 24
Late Erythema 8-10wks 15
Telangiectasia >1yr 10
Necrosis >1Yr >12
Radiation Effects on Skin (Wagner, 1994)
102. 102
īŽ Mettler, 2008 â Skin erythema or reddening occurs
if a single dose of 6 to 8 Gray is given and is not
identified till 1 to 2 days after irradiation.
īŽ Balter, 2010 â For most patients, clinically important
skin and hair reactions occur only when the skin
dose is higher than 5 Gy.
īŽ ICRP Pub. 59 â Early erythematous reaction well
documented in man is seen within a few hours after
irradiation of large fields with acute doses of > 2
Gray.
Radiation Effects on Skin
103. Cutaneous Radiation Injury (CRI)
īŽ Visit the following website
īŽ http://www.bt.cdc.gov/radiation/criphysicianfactsheet.asp
īŽ http://www.fda.gov/Radiation-EmittingProducts/RadiationEmittin
104. Course of Cutaneous Radiation
Injury (CRI)
īŽ Visible effects and their severity depend
on magnitude of dose and depth of
radiation penetration (plus size of
irradiated area)
īŽ Visible effects generally do not appear
for hours or days post exposure
īŽ CRI progresses in stages
īŽ CRI can be graded by severity
105. Stages of CRI
īŽ Prodromal
īŽ Latent
īŽ Manifest illness
īŽ Third wave erythema
īŽ Recovery
īŽ Late effects
106. Prodromal Stage
īŽ Early, transient erythema (âfirst waveâ)
possible
īŽ Sensations of heat and itching possible
īŽ Appearance within/duration typically 1-2
days
107. 107
Radiation Effects on Skin
īŽ Early transient erythema
īŽ May be seen within a few hours after
irradiation of large fields (15x20 cm) and
subsides after 24 â 48 hours.
īŽ Response is early phase of inflammation
from increased permeability in the
capillaries.
īŽ The repair of sub-lethal damage to DNA
is completed within 24 hours.
Ref: ICRP Pub. 59
108. Latent Stage
īŽ No apparent injury or symptoms
īŽ Lasts generally <1 to 2 days
109. Manifest Injury Stage
īŽ Main erythema (âsecond waveâ)
īŽ Sense of heat
īŽ Edema possible
īŽ Pigmentation changes
īŽ Appears and lasts days to weeks post
exposure
113. Late Effects
īŽ Doses above ~ 1000 rad
īŽ Skin atrophy
īŽ Ulcer recurrence
īŽ Telangiectasia (dilation of capillaries or
terminal arteries)
īŽ Skin cancer risk increases
114. Note - As Dose Goes Up:
īŽ Time to symptom appearance shortens.
īŽ Lengths of prodromal and latent periods
shorten.
īŽ Length of manifest injury period
increases.
īŽ Healing takes longer and becomes
more difficult.
īŽ Severity of injuries increases.
134. Nuclear Medicine Occupational Risks
īŽ The preceding described injuries are deterministic
effects (i.e., have a threshold).
īŽ Normal occupational dose levels are below
deterministic effect thresholds.
īŽ Only a non-deterministic theoretical cancer risk
increase is possible.
īŽ Extended skin contamination by sufficient activity of
higher energy charged particle emitters like I-131
(initial beta skin dose rate on the order of 6.5 rad per
microcurie per cm2
skin deposition) could conceivably
result in deterministic effects.
Case 3: Another deep tissue radiation induced ulcer and tissue necrosis, 21 months after a coronary angiography and 2 angioplasty procedures within a 3 day period. The estimated cumulative dose to the patient was 15,000-20,000 mGy.
Used with the permission of ICRP, Publication 85.
Case 2, Image 4: At 22 months, it becomes evident that this is a non-healing ulcer. Deep tissues and spinous process of vertebra are exposed.
Provided with permission from the American Roentgen Ray Society.
Koenig, T.R., Mettler, F.A., Wagner, L.K., et al., 2001. Skin Injuries from Fluoroscopically Guided Procedures Part 1, Characteristics of Radiation Injury. American Journal of Roentgenology. 177, 3-11.
Case 2, Image 2: At 7 ÂŊ months small blisters develop around the ulceration.
Used with the permission of Louis K. Wagner, Ph.D., University of Texas â Houston Medical School.
Case 2, Image 3: Size and depth of the wound continues to increase at 10 months.
Used with the permission of Louis K. Wagner, Ph.D., University of Texas â Houston Medical School.
Case 2, Image 4: At 22 months, it becomes evident that this is a non-healing ulcer. Deep tissues and spinous process of vertebra are exposed.
Provided with permission from the American Roentgen Ray Society.
Koenig, T.R., Mettler, F.A., Wagner, L.K., et al., 2001. Skin Injuries from Fluoroscopically Guided Procedures Part 1, Characteristics of Radiation Injury. American Journal of Roentgenology. 177, 3-11.
Case 2, Image 5: At 23 months skin grafting is performed. Disfigurement and certain motor function impairment is permanent.
Used with the permission of Louis K. Wagner, Ph.D., University of Texas â Houston Medical School.
Case 4: This is a 57 year old with coronary disease involving the left circumflex artery. He underwent several angioplasties with stent placements. 5 months later, a similar procedure was performed for the left anterior descending artery. Both procedures were performed with steep fluoro beam angulation.
The 1st picture was taken 1 year after the 2nd procedure. You see an ulcer formation here and a lower lesion here from the 2nd intervention. At the time of 2nd procedure the cause of the 1st lesion, which probably looked similar to this, was not recognized.
The 2nd picture was taken 2 years after last procedure and you see the grafting required by the lesion.
Provided with permission from the American Roentgen Ray Society
Koenig, T.R., Mettler, F.A., Wagner, L.K., et al., 2001. Skin Injuries from Fluoroscopically Guided Procedures Part 2, Review of 73 Cases and Recommendations for Minimizing Dose Delivered to Patient. American Journal of Roentgenology. 177, 13-20.
Case 5: This patient underwent radiofrequency cardiac catheter ablation for arrythmia. Her arm was either incorrectly or inadvertently positioned in the direct fluoro beam, approximately 8 â 10 inches from the x-ray source. The automatic brightness control would have driven the x-ray intensity to higher than normal levels in order to penetrate the extra tissue and bone of the arm.
Estimates of exposure rates to the arm indicate they likely exceeded 50 rad/min in Normal mode. If the High Dose Rate mode was engaged, as has been indicated for this case, the rates could have been in excess of 180 rads/min. The total fluoro time was reported to be about 20 minutes. Based on the level of damage, it is thought that the patientâs arm was exposed to at least 2,500 rads. The purported reason for going to the High Dose Rate mode was due to the âshadowy pictureâ, that in hindsight turned out to be the humerus.
In Image 1 we see erythema about 3 weeks after the procedure.
In Image 2, The ulcer is fully developed at about 5 months.
Used with permission.
Wagner, L.K., Archer, B.R., 1998. Minimizing Risks from Fluoroscopic X Rays: Bioeffects, Instrumentation, and Examination. Partners in Radiation Management, The Woodlands, TX, USA.
Case 5 continued:
In Image 3, At 6 ÂŊ months the humerus is clearly visible.
In Image 4, 10 months after the procedure we see that surgical flap grafting has been done.
Used with permission.
Wagner, L.K., Archer, B.R., 1998. Minimizing Risks from Fluoroscopic X Rays: Bioeffects, Instrumentation, and Examination. Partners in Radiation Management, The Woodlands, TX, USA.